课题基金 / 基金详情

GASTRIC ACID SECRETION RESPONSE IN PATIENTS W/ GASTROESOPHAGEAL REFLUX DISEASE

GASTRIC ACID SECRETION RESPONSE IN PATIENTS W/ GASTROESOPHAGEAL REFLUX DISEASE
胃食管反流病患者的胃酸分泌反应
批准号：
6265323
负责人：
JOSEPH R PISEGNA
金额：
$0.19万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6265323
关键词：
clinical research dosage gastric acid gastrointestinal agents gastrointestinal disorder chemotherapy human subject human therapy evaluation oral administration reflux esophagitis secretion

项目摘要

项目成果

JOSEPH R PISEGNA的其他基金

相似基金

相关文献

中文摘要
翻译
泮托拉唑是一种质子泵抑制剂（PPI），可抑制胃酸分泌。 口服剂型目前正在开发用于胃食管反流病（GERD）相关糜烂性食管炎的急性治疗和维持治疗。 IV形式正在美国开发，用于治疗不能口服药物的患者。
英文摘要
Pantoprazole is a proton pump inhibitor (PPI) that suppresses gastric acid secretion. The oral dosage form is currently in development for both the acute treatment of and maintenance therapy pf gastroesphageal reflux disease (GERD) -associated erosive esophagitis. The IV form is being developed in the US for the treatment of patients that cannot take oral medication.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ShEEP Request for Acquisition a 10x Genomics Single Cell RNA Sequencer
CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
海外基金